About Soneas
Soneas is a company based in Budapest (Hungary) founded in 1996 was acquired by Uquifa in May 2018. Soneas offers products and services including Discovery Process, R&D Services, GMP Manufacturing, and Large Scale Manufacturing. Soneas operates in a competitive market with competitors including Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
- Headquarter Budapest, Hungary
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Soneas Chemicals Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Uquifa
(May 16, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Soneas
Soneas offers a comprehensive portfolio of products and services, including Discovery Process, R&D Services, GMP Manufacturing, and Large Scale Manufacturing.
Early phase development for chemical projects and trials.
Supports chemistry understanding and innovation processes.
cGMP production of APIs and intermediates for trials.
ISO-certified large-scale chemical manufacturing operations.
Funding Insights of Soneas
Investors in Soneas
Soneas has secured backing from 1 investor. Prominent investors backing the company include UQUIFA Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO company manufacturing APIs and intermediates
|
Founded Year | Domain | Location |
Investments & Acquisitions by Soneas
Financial Statements - Soneas
Soneas Comparisons
Competitors of Soneas
Soneas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| domain | founded_year | HQ Location |
APIs are manufactured and custom synthesis services are provided.
|
Frequently Asked Questions about Soneas
Soneas was founded in 1996.
Soneas is headquartered in Budapest, Hungary.
Soneas (formerly known as Ubichem Pharma Group) is a CDMO offering its services for API and intermediate development. The company uses catalytic olefine metathesis, in addition to other traditional manufacturing methods. The companys service portfolio includes process development (including Route selection and safety evaluation, Availability and cost of key raw materials, Process optimisation and scale-up, and Isolation and purification), cGMP API manufacture (Preclinical to commercial supply through kilo labs and pilot plants), Intermediate custom synthesis and manufacture, and analytical support services (Analytical MD MV,Impurities reference standards, Salt screening crystallisation studies, Stability studies). Soneas has a strategic partnership with XiMO AG, a Swiss-based company focused on the development and application of proprietary metathesis catalysts and founded by Richard R. Schrock, the co-winner of 2005 Nobel prize. Metathesis catalysts made up of Molybdenum and Tungsten are cheaper than those made up of Ruthenium and also help in reducing the catalytic load.
Soneas's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Soneas offers Discovery Process, R&D Services, GMP Manufacturing, and Large Scale Manufacturing.
Soneas has 1 investor. Key investors include UQUIFA Group.